PK/PD approach to dose selection

International Congress Series

Volumn 1220, Issue C, 2001, Pages 67-78

  Sheiner, Lewis B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dosage; Modeling; PK PD; Response surface; Utilities

Indexed keywords

EID: 18044381077     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00287-4     Document Type: Article

References (11)

1. Petitti, D.B., Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine, 2nd edn., 2000, Oxford University Press, New York.
2. Sheiner, L.B., Learning vs. confirming in clinical drug development. Clin. Pharmacol. Ther. 61 (1997), 275–291.
3. Box, G.E.P., Use and abuse of regression. Technometrics 8 (1966), 625–628.
4. Davidian, M., Giltinan, D.M., Nonlinear models for repeated measurement data, 1995, Chapman & Hall, New York.
5. Angrist, J.D., Imbens, G.W., Rubin, D.B., Identification of causal effects using instrumental variables. J. Am. Stat. Assoc. 91 (1996), 444–472.
6. Rubin, D.B., Comment: Neyman (1923) and causal inference in experiments and observational studies. Stat. Sci. 5 (1991), 472–480.
7. Rubin, D.B., Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism. Biometrics 47 (1991), 1213–1234.
8. Sheiner, L.B., Rubin, D.B., Intention to treat analysis and the goals of clinical trials. Clin. Pharmacol. Ther. 57 (1995), 6–15.
9. Sheiner, L.B., Ludden, T.M., Population pharmacokinetics/dynamics. Annu. Rev. Pharmacol. Toxicol. 32 (1992), 185–209.
10. Sheiner, L.B., Steimer, J.-L., Pharmacokinetic/pharmacodynamic modelling in drug development. Annu. Rev. Pharmacol. Toxicol. 40 (2000), 67–96.
11. Sheiner, L.B., Beal, S.L., Dunne, A., Analysis of non-randomly censored ordered categorical longitudinal data from analgesic trials (with Discussion). J. Am. Stat. Assoc. 92 (1997), 1235–1255.